Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Glenmark Pharmaceuticals (GNP IN)
Watchlist
128
Analysis
Health Care
•
India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
17 May 2024 20:15
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachment
Exchange Announcement •
17 May 2024 11:30
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attachment
Exchange Announcement •
15 May 2024 20:34
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachment
Exchange Announcement •
14 May 2024 19:14
GLENMARK PHARMACEUTICALS LTD. - 532296 - Closure of Trading Window
Attachment
Exchange Announcement •
14 May 2024 19:10
GLENMARK PHARMACEUTICALS LTD. - 532296 - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2024 And Recommending Dividend, If Any, On Equity Shares For The Year Ended March 31, 2024
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.0
x